Navigation Links
VITROS® HBsAg Assay

ProductsVITROS® HBsAg Assay
Company Ortho-Clinical Diagnostics
Item VITROS® HBsAg Assay
Features 
  • Reduces the need for repeat testing and confirmation testing with certain samples1
  • Provides laboratory diagnosis of individuals with acute or chronic hepatitis B in conjunction with other serological and clinical information
  • May be used to screen for hepatitis B infection in pregnant women to identify neonates who are at high risk for acquiring HBV during the perinatal period
  • Results available in 37 minutes
  • Description The VITROS HBsAg assay is the second diagnostic hepatitis assay approved by the U.S. Food and Drug Administration capable of being run in a random access format on the VITROS ECi Immunodiagnostic System with Intellicheck. Now you can run an HBsAg test 24/7 in the U.S. and provide results in 37 minutes.
    Info Ortho-Clinical DiagnosticsCall Ortho-Clinical Diagnostics to buy products (US and Canada only; other locations use number below) USACanada1-866-802-9580

    Customer Service: 1-800-828-6316
    Web site: http://www.orthoclinical.com

    Related medicine products :

    1. VITROS® Anti-HBs Assay
    2. VITROS® Anti-HCV Assay
    3. Genetic Systems HBsAg EIA 3.0
    4. Hepatitis B Virus Panel, Chronicwith Reflex to HBsAg Confirmation
    5. Hepatitis Panel, Acute with Reflex to HBsAg Confirmation
    6. Determine HBsAg - Serum & Blood
    7. Determine HBsAg - Whole blood (includes chase buffer)
    8. Uric Acid Enzymatic Assay
    9. Lithium Enzymatic Assay Kit
    10. Retinol Binding Protein EIA Vitamin Assays 030-6110 RBP Bone and Minearl Metabolism
    11. Vitamin B6 Jumbo REA Vitamin Assays, Cardiovascular 001-RK-VB6N
    ...s for performing erythrocyte sedimentation rate (E...on of the Ves-matic System DIESSE brings to the cl...ting system which addresses and resolves every tec...ESR techique.,By means of a fully automated analyz...
    ...s for performing erythrocyte sedimentation rate (E...on of the Ves-matic System DIESSE brings to the cl...ting system which addresses and resolves every tec...ESR techique.,By means of a fully automated analyz...
    ...ntation rate analysers, which are especially user-...well-established advantages of the existing analys...ch guarantee time-saving standardised analysis of ...ness is an essential aspect of daily recurrent rou...
    Mix-Rate
    Medicine Products:
    (Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th
    (Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
    (Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be
    (Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
    (Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
    Breaking Medicine News(10 mins):Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3
    ...isk of developing liver cancer and more than twice...researchers based on findings of a recent study. ...agnosed with 12 different types of cancer to 509 h...pendent of other factors like participants' body m...
    ...researchers suggest that the risk factors for hear...nearly 2,000 teens studied, about two-thirds had a... as 10 percent had a cluster of risk factors known... heart disease and diabetes. For the purpose of th...
    ...tic hypotension have problems with sinking blood p.../ Current treatments help increase blood pressure ...r when lying down, increasing the risk for stroke....ic hypotension especially common in those over age...
    ...ncer death worldwide, accounting for more than 1.3...rd to detect in early and treatable stages, most c...tudies have shown CT scans can identify the diseas...ecent study, researchers used PET scans to confirm...
    ...benefit from early magnetic resonance imaging, acc...o neuroscientists in Canada MRI technology could d...ients. They say they found that trauma-induced spi...ly certain the procedure will benefit the patient,...
    ... in soy could be good for the hearts and bones of ...parate studies suggest the natural plant estrogens...the body's own estrogen, therefore making soy espe...tter cholesterol levels compared to monkeys who at...
    Other Medicine News:Health News:New Drug Effective for Low Blood Pressure 2
    (Date:12/4/2009)EMERYVILLE, Calif., Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it will host an investor teleconference and webcast. Principal investigators will discuss the data present
    (Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today the presentation of new d
    (Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is prese
    Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB 728 T for HIV AIDS 14909 1Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB 728 T for HIV AIDS 14909 2FREE Drug Discount Card Saves Money on Prescriptions and Raises Funds for Americas Disabled Veterans 6392 1FREE Drug Discount Card Saves Money on Prescriptions and Raises Funds for Americas Disabled Veterans 6392 2Genital Herpes May Never Go Dormant 61659 1Genital Herpes May Never Go Dormant 61659 2Genital Herpes May Never Go Dormant 61659 3